Gilead’s Potential ‘Coronacure’ Can’t Save the U.S. Economy from Doom
A coronavirus treatment called remdesivir from Gilead Sciences looks promising. But Friday’s stock market ascent isn’t warranted. What’s coming down the economic pipeline even if a successful cure is approved tomorrow? The U.S. stock market surged on Friday because of late news about Gilead Sciences’ (NASDAQ: GILD) promising coronavirus treatment, remdesivir. Is the market’s response…